Maynard Um
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO)
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) PT Raised to $96 at TD Cowen
-
-
-
-
-
-
-
Halozyme (HALO) Has Compelling Upside Driver in MDASE royalty - Citizens
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) Tops Q3 EPS by 11c, provides guidance
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Halozyme Therapeutics (HALO)
-
-
-
-
-
-
-
European Commission approves Halozyme's DARZALEX Faspro for smouldering multiple myeloma
-
-
-
-
-
-
-
Increasing unusual call option volume: PSX XLI HALO ARRY SATS SHLS AVTR
-
421,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

